Matches in Wikidata for { <http://www.wikidata.org/entity/Q92273872> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q92273872 description "clinical trial" @default.
- Q92273872 description "ensayo clínico" @default.
- Q92273872 description "ensayu clínicu" @default.
- Q92273872 description "klinisch onderzoek" @default.
- Q92273872 description "клінічне випробування" @default.
- Q92273872 description "临床试验" @default.
- Q92273872 name "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase (ALK) -Positive NSCLC" @default.
- Q92273872 name "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase" @default.
- Q92273872 type Item @default.
- Q92273872 label "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase (ALK) -Positive NSCLC" @default.
- Q92273872 label "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase" @default.
- Q92273872 prefLabel "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase (ALK) -Positive NSCLC" @default.
- Q92273872 prefLabel "Study of Lorlatinib In Participants With Anaplastic Lymphoma Kinase" @default.
- Q92273872 P1050 Q92273872-F8B3CCA8-5779-470D-AF7D-8049B30E5676 @default.
- Q92273872 P1132 Q92273872-AAF9F669-EC64-4442-97DA-E77987BED043 @default.
- Q92273872 P1476 Q92273872-439B185C-406B-43F5-83FE-7D21E3AF48C5 @default.
- Q92273872 P2899 Q92273872-49942E6C-B0A9-4C12-AAF0-D49F1C926503 @default.
- Q92273872 P3098 Q92273872-A4A2B9D0-5EC4-48CF-91BE-985EEE6E7827 @default.
- Q92273872 P31 Q92273872-7AD1A242-65F8-4B5A-A0DC-5DE5A02AB2A1 @default.
- Q92273872 P580 Q92273872-2269A433-4115-4590-9531-9CDAC0F85835 @default.
- Q92273872 P582 Q92273872-CE3FD36E-24AC-47DD-8128-4F616F6637F5 @default.
- Q92273872 P6099 Q92273872-E3F4B879-5B63-466B-987E-3456AB4A0D98 @default.
- Q92273872 P8005 Q92273872-29944749-0692-40D3-A58B-2637986B5D15 @default.
- Q92273872 P8363 Q92273872-A1C64C04-32D3-4B47-A4DD-369759B232A6 @default.
- Q92273872 P859 Q92273872-40C51A19-2E98-4B86-AC4C-A0D3DCBB7A22 @default.
- Q92273872 P1050 Q208414 @default.
- Q92273872 P1132 "+85" @default.
- Q92273872 P1476 "Single-Arm Study of Lorlatinib in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) Whose Disease Progressed After One Prior Second-Generation ALK Tyrosine Kinase Inhibitor (TKI)" @default.
- Q92273872 P2899 "+18" @default.
- Q92273872 P3098 "NCT04362072" @default.
- Q92273872 P31 Q30612 @default.
- Q92273872 P580 "2020-04-17T00:00:00Z" @default.
- Q92273872 P582 "2023-10-17T00:00:00Z" @default.
- Q92273872 P6099 Q42825046 @default.
- Q92273872 P8005 Q76649614 @default.
- Q92273872 P8363 Q78089383 @default.
- Q92273872 P859 Q206921 @default.